International Drug Development Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:International Drug Development Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9328
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical services comprise study design, clinical development strategy, biostatistical analysis, interim analysis, biomarker validation and medical writing, among others. IDDI’s risk-based monitoring services include risk indicator and central statistical monitoring. The institute offers clinical research services in therapeutic areas of cancer research, ophthalmology, rare diseases and biosimilars. It caters to pharmaceutical companies, biotechs, start-ups, academic groups and CROs. IDDI is headquartered in Louvain-la-Neuve, Belgium.

International Drug Development Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Drug Development Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International Drug Development Institute, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
International Drug Development Institute Partners with Ophthotech 10
International Drug Development Institute Partners with Oraya Therapeutics 11
International Drug Development Institute Partners with Exonhit 12
International Drug Development Institute – Key Competitors 13
International Drug Development Institute – Key Employees 14
International Drug Development Institute – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
International Drug Development Institute, Pharmaceuticals & Healthcare, Key Facts 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Drug Development Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Drug Development Institute, Deals By Therapy Area, 2012 to YTD 2018 8
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International Drug Development Institute Partners with Ophthotech 10
International Drug Development Institute Partners with Oraya Therapeutics 11
International Drug Development Institute Partners with Exonhit 12
International Drug Development Institute, Key Competitors 13
International Drug Development Institute, Key Employees 14
International Drug Development Institute, Subsidiaries 15

List of Figures
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Drug Development Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[International Drug Development Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lea County Electric Cooperative Inc:企業の発電所・SWOT分析2018
    Lea County Electric Cooperative Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Naturgy Energy Group SA. (NTGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Naturgy Energy Group SA (Naturgy) formerly know as Gas Natural Fenosa, is an integrated gas and electric utility that carries out the exploration, development, liquefaction, regasification, transportation, storage, distribution and commercialization of natural gas. It also undertakes the gen …
  • Interleukin Genetics Inc (ILIU)-医療機器分野:企業M&A・提携分析
    Summary Interleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include ILUSTRA genetic risk test ; cardiovascular risk test; weight management genetic test; bone health genetic …
  • Landstar System, Inc.:戦略・SWOT・企業財務分析
    Landstar System, Inc. - Strategy, SWOT and Corporate Finance Report Summary Landstar System, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hainan Shuangcheng Pharmaceuticals Co Ltd (002693):製薬・医療:M&Aディール及び事業提携情報
    Summary Hainan Shuangcheng Pharmaceuticals Co Ltd (Shuangcheng Pharma) is a pharmaceutical company that develops, manufactures and markets generic peptide drugs, finished dosages and active pharmaceutical ingredients. Its products include thymalfasin, thymopetin, somatostatin, levocarnitine, famotid …
  • A. Menarini Industrie Farmaceutiche Riunite Srl:企業の戦略的SWOT分析
    A. Menarini Industrie Farmaceutiche Riunite Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析
    Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Team Energy Corp:企業の戦略的SWOT分析
    Team Energy Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • TYI 2011 Ltd:企業の戦略的SWOT分析
    TYI 2011 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CeoTronics AG (CEK):企業の財務・戦略的SWOT分析
    CeoTronics AG (CEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • WKN AG:電力:M&Aディール及び事業提携情報
    Summary WKN AG (WKN), formerly WKN WindKraft Nord AG, a subsidiary of PNE Wind AG, is a renewable energy service provider that develops wind farms and various photovoltaic projects. The company offer services portfolio includes project planning, development, financing, realisation, and repowering. I …
  • CVS Health Corp (CVS):製薬・医療:M&Aディール及び事業提携情報
    Summary CVS Health Corporation (CVS) is an integrated prescription and related health services provider. The company offers a range of solutions such as prescription medications; health care products; popular beauty, health and personal care brands; retail-based health clinical services; and pharmac …
  • QEP Resources Inc (QEP):企業の財務・戦略的SWOT分析
    QEP Resources Inc (QEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • HNA Group Co Ltd:企業のM&A・事業提携・投資動向
    HNA Group Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HNA Group Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Health Care Service Corporation:企業の戦略・SWOT・財務分析
    Health Care Service Corporation - Strategy, SWOT and Corporate Finance Report Summary Health Care Service Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Mikros Systems Corporation:企業の戦略・SWOT・財務情報
    Mikros Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Mikros Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • University of Pennsylvania:医療機器:M&Aディール及び事業提携情報
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • Australian Gas Networks Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Australian Gas Networks Ltd (Australian Gas Networks), formerly Envestra Ltd is an oil and gas company that distributes and transports natural gas. The company's services include managing the haulage of gas through each network, operation and maintenance of gas network, design an constructio …
  • Contact Energy Ltd (CEN):企業の財務・戦略的SWOT分析
    Contact Energy Ltd (CEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Public Broadcasting Service:企業の戦略・SWOT・財務情報
    Public Broadcasting Service - Strategy, SWOT and Corporate Finance Report Summary Public Broadcasting Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆